Turnstone Biologics Corp. (TSBX)
NASDAQ: TSBX · Real-Time Price · USD
0.4100
-0.0010 (-0.24%)
Mar 31, 2025, 10:46 AM EDT - Market open
Turnstone Biologics Market Cap
Turnstone Biologics has a market cap or net worth of $9.48 million as of March 31, 2025. Its market cap has decreased by -85.79% in one year.
Market Cap
9.48M
Enterprise Value
-34.08M
1-Year Change
-85.79%
Ranking
Category
Stock Price
$0.41
Market Cap Chart
Since the IPO on July 21, 2023, Turnstone Biologics's market cap has decreased from $255.86M to $9.48M, a decrease of -96.29%. That is a compound annual growth rate of -85.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 9.51M | -17.29% |
| Dec 31, 2024 | 11.49M | -80.45% |
| Dec 29, 2023 | 58.77M | -77.03% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |